Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fibrinogen/fibrin in atherogenesis.

E B Smith1, W D Thompson, L Crosbie

  • 1Department of Clinical Biochemistry, University of Aberdeen, Aberdeen Royal Infirmary.

European Journal of Epidemiology
|May 1, 1992
PubMed
Summary

Fibrin in atherosclerotic plaques can release lipoprotein(a) [Lp(a)] via plasmin. Lp(a)

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beta Decay of Molecular Tritium.

Physical review letters·2020
Same author

Occurrence of Cowpea Stunt Disease Causing Viruses on Wild Bean in Arkansas.

Plant disease·2019
Same author

A randomised controlled trial comparing a dietary antiplatelet, the water-soluble tomato extract Fruitflow, with 75 mg aspirin in healthy subjects.

European journal of clinical nutrition·2016
Same author

SOCIAL WORK EDUCATION.

A listing of research in the cardiovascular field·2014
Same author

Singlet oxygen in the environmental sciences. Role of singlet molecular oxygen in the production of photochemical air pollution.

Environmental science & technology·2011
Same author

Rupture of the spleen in infectious mononucleosis; a clinicopathologic report of 7 cases.

Blood·2010

Area of Science:

  • Cardiovascular research
  • Atherosclerosis and thrombosis
  • Lipoprotein metabolism

Background:

  • Fibrin is a key component of atherosclerotic plaques.
  • Continuous fibrin formation and breakdown occur within the arterial intima.
  • Lipoprotein(a) [Lp(a)] is implicated in cardiovascular disease.

Purpose of the Study:

  • To investigate the relationship between fibrin and Lp(a) in aortic lesions.
  • To explore the atherogenic mechanisms of Lp(a).

Main Methods:

  • Analysis of aortic lesions.
  • Incubation with plasmin to release bound lipoproteins.
  • Characterization of released lipoproteins, primarily Lp(a).

Main Results:

  • A fibrin-bound lipoprotein, largely Lp(a), can be released from aortic lesions by plasmin.
  • Lp(a)'s atherogenicity may stem more from lipid deposition than fibrinolysis inhibition.
  • Fibrin degradation products may attract monocyte-macrophages and promote smooth muscle cell proliferation.

Conclusions:

  • Fibrin plays a role in retaining Lp(a) within atherosclerotic plaques.
  • Lp(a) contributes to atherosclerosis through lipid accumulation.
  • Fibrin breakdown products may influence inflammatory and proliferative processes in the arterial wall.

Related Experiment Videos